8-K: Vivakor Secures Debt Forbearance, Nasdaq Reinstatement Path

Vivakor, Inc. has entered into a forbearance agreement with J.J. Astor & Co. to extend its debt maturity and establish a repayment plan, while also committing to Nasdaq reinstatement efforts.

Summary

• Vivakor, Inc. (VIVK) entered a Forbearance and Note Payment Amendment Agreement with J.J. Astor & Co. on February 5, 2026.
• The agreement addresses existing defaults on a $5,940,000 junior secured convertible promissory note, which had an outstanding balance of $5,995,722.21 as of the effective date.
• The maturity date of the note has been extended from January 7, 2026, to January 1, 2027.
• During the forbearance period, interest on the outstanding balance will accrue at 9% per annum, compounded daily.
• Vivakor committed to a weekly repayment schedule starting April 6, 2026, with payments escalating from $50,000 to $250,000 per week, aiming for full repayment by January 1, 2027.
• The company has the option to make payments in common stock (Conversion Shares) if specific conditions related to stock price, trading volume, and ownership limits are met, and shareholder approval is obtained if shares exceed 19.99% of voting securities.
• Vivakor must use best efforts to be reinstated on the Nasdaq Capital Market by February 28, 2026, with a potential extension to April 30, 2026, if a reverse stock split application is filed.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a highly distressed situation. While the forbearance agreement provides a temporary reprieve and a structured repayment plan, the company is already in default, faces significant weekly payments, and is under pressure to regain Nasdaq compliance, all with severe penalties for non-compliance.

Positives

• Maturity date of the $5,995,722.21 outstanding note extended from January 7, 2026, to January 1, 2027, providing more time for repayment.
• Interest rate reduced to 9% compounded daily during the forbearance period, potentially lowering immediate interest costs compared to a default rate.
• Company has the flexibility to pay installments in common stock, subject to certain conditions, which could preserve cash.
• The agreement provides a structured path to address existing defaults and avoid immediate acceleration of the debt.

Negatives

• Vivakor was already in default on its $5,940,000 promissory note, with an outstanding balance of $5,995,722.21.
• Failure to comply with the new repayment terms or Nasdaq reinstatement deadline will result in severe penalties, including the outstanding principal increasing to 110% and an interest rate of 19% compounded daily, with immediate full repayment due.
• The company is restricted from issuing new convertible promissory notes or other common stock equivalents until the existing note is fully paid, limiting future financing options, with a small exception for up to $1 million in unregistered convertible notes with non-more-favorable terms.
• Requires shareholder approval by May 31, 2026, to increase authorized common stock and approve the loan agreements, indicating potential dilution if stock payments are made or a reverse split occurs.
• The company is currently suspended from trading on the Nasdaq Capital Market and faces a tight deadline for reinstatement.

Risks

• Default Risk: Failure to comply with the Amended Repayment Terms or meet the Nasdaq Reinstatement Deadline will trigger an increase in the outstanding principal to 110%, an interest rate of 19% per annum compounded daily, immediate full repayment, and termination of forbearance.
• Liquidity Risk: The company faces significant weekly payment obligations starting April 6, 2026, escalating to $250,000 per week by December 7, 2026, which could strain cash flow.
• Dilution Risk: If the company opts to pay in Conversion Shares, and if shareholder approval is obtained to increase authorized stock, existing shareholders could face significant dilution.
• Delisting Risk: Failure to achieve Nasdaq reinstatement by the specified deadlines (February 28, 2026, or April 30, 2026, with reverse split application) could lead to delisting, impacting liquidity and investor confidence.
• Financing Risk: Restrictions on issuing new Common Stock Equivalents limit the company's ability to raise capital through convertible debt or equity until the existing note is repaid.
• Shareholder Approval Risk: The requirement to obtain shareholder approval by May 31, 2026, for increasing authorized shares and approving the loan agreements introduces uncertainty and potential delays.

Future Outlook

Vivakor aims to remove its suspension from trading and be reinstated on the Nasdaq Capital Market by February 28, 2026, with a potential extension to April 30, 2026, if a reverse stock split application is filed. The company also plans to call a shareholder meeting by May 31, 2026, to approve an increase in authorized common stock and the loan agreements, which is crucial for its ability to make stock payments and manage its capital structure.

Management Comments

• Vivakor acknowledges and confirms the occurrence of the Existing Defaults.
• The Company agrees to use its best efforts to remove its suspension from trading on the Nasdaq Capital Market and be reinstated for trading on the Nasdaq Capital Market on or before February 28, 2026.

Industry Context

StockSavvy.ai notes that companies facing delisting from major exchanges like Nasdaq often enter into forbearance agreements to restructure debt and gain time to regain compliance. This situation highlights the challenges smaller companies can face in managing debt obligations and maintaining listing standards, especially when operational cash flow is insufficient. The requirement for a reverse stock split suggests the company's share price is likely below Nasdaq's minimum bid price requirement, a common issue for companies struggling with financial performance or market sentiment.

Corporate Governance

Legal Proceedings

• The company acknowledges and confirms the occurrence of "Existing Defaults" under the Loan Agreement and Note, including failure to repay the Note by its January 7, 2026, maturity date.

Stakeholder Impact

• Shareholders: Potential for significant dilution if the company pays in stock or effects a reverse stock split. Required shareholder meeting for approval of authorized stock increase and loan agreements gives shareholders a voice but also highlights the company's precarious position. Delisting from Nasdaq would severely impact liquidity and share value.
• Creditors (J.J. Astor & Co.): The agreement provides a structured repayment plan and extends the maturity date, but also includes severe penalties if the company defaults again, protecting the lender's interests.
• Employees/Operations: The financial distress and focus on debt repayment and Nasdaq compliance could divert resources and attention from core business operations, potentially impacting employees.

Next Steps

• Commence weekly payments of $50,000 starting April 6, 2026, escalating thereafter.
• Use best efforts to remove suspension and be reinstated on the Nasdaq Capital Market by February 28, 2026.
• If necessary, apply for a reverse stock split prior to February 28, 2026, to extend the Nasdaq reinstatement deadline to April 30, 2026.
• Call a regular or special meeting of stockholders by May 31, 2026, to approve increasing authorized common stock and the loan agreements.
• Pay the outstanding balance of the Second Note in full by January 1, 2027.

Key Dates

Recommendation

The company is in a highly precarious financial position, having already defaulted on a significant debt. While the forbearance agreement offers a temporary lifeline, it comes with stringent repayment terms, a high default interest rate, and severe penalties for non-compliance. The ongoing Nasdaq suspension and the need for a reverse stock split indicate fundamental issues with the company's market valuation and compliance. Restrictions on future capital raises through convertible instruments further limit its ability to address these challenges. The risk of further default, delisting, and significant shareholder dilution is very high, making this a strong sell for investors.

Keywords

Vivakor, VIVK, 8-K, SEC Filing, Forbearance Agreement, Promissory Note, Debt Restructuring, Nasdaq Compliance, Delisting Risk, Convertible Debt, Shareholder Approval, Financial Default, J.J. Astor & Co., Loan Agreement, Reverse Stock Split